Crispr/cas-related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (lca10)

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.


Claims

Information currently unavailable.

Download Citation


Sign in to the Lens

Feedback